drugset / Trial / NCT06238011
Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
Aim to study efficacy of dexmedetomidine to attenuate hemodynamic response to intubation, skin incision, sternotomy and aortic cannulation
Timeline
- Start
- 2024-02-28
- Primary completion
- 2024-04-30
- Completion
- 2024-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | — |
Indications
No indication recorded.